Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests

Hepatology

Volumn 55, Issue 2, 2012, Pages 530-539

  Felipo, Vicente ^a   Ordoño, Juan F ^b,c   Urios, Amparo ^d   El Mlili, Nisrin ^d   Giménez Garzó, Carla ^a   Aguado, Carolina ^d   González Lopez, Olga ^b   Giner Duran, Remedios ^b   Serra, Miguel A ^d   Wassel, Abdallah ^d   Rodrigo, Jose M ^e   Salazar, José ^c   Montoliu, Carmina ^d  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINIMAL MISMATCH NEGATIVITY; MISMATCH NEGATIVITY; PREDICTION; PRIORITY JOURNAL; TASK PERFORMANCE; VISUOMOTOR COORDINATION;

ADULT; ATTENTION; CASE-CONTROL STUDIES; EVOKED POTENTIALS, AUDITORY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHOMETRICS; STROOP TEST;

EID: 84856386174     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24704     Document Type: Article

References (41)

1. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004; 19: 253-267.
2. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy. Definition, nomenclature, diagnosis and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. HEPATOLOGY 2002; 35: 716-721.
3. Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Ferrandez A, Rodrigo JM, et al. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients. J Mol Med 2007; 85: 233-241.
4. Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, et al. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 2009; 43: 272-279.
5. Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-2723.
6. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. HEPATOLOGY 1998; 28: 45-49.
7. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. HEPATOLOGY 2004; 39: 739-745.
8. Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR, et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. HEPATOLOGY 2009; 50: 1175-1183.
9. Romero-Gómez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. HEPATOLOGY 2004; 39: 939-943.
10. Román E, Córdoba J, Torrens M, Torras X, Villanueva C, Vargas V, et al. Minimal hepatic encephalopathy is associated with falls. Am J Gastroenterol 2011; 106: 476-482.
11. Elsass P, Lund Y, Ranek L. Encephalopathy in patients with cirrhosis of the liver. A neuropsychological study. Scand J Gastroenterol 1978; 13: 241-247.
12. Amodio P, Marchetti P, Del Piccolo F, Sartori G, Prior M, Merkel C, Gatta A. Visual attention orienting in liver cirrhosis without overt hepatic encephalopathy. Metab Brain Dis 1995; 10: 335-345.
13. Amodio P, Marchetti P, Del Piccolo F, Campo G, Rizzo C, Iemmolo RM, et al. Visual attention in cirrhotic patients: a study on covert visual attention orienting. HEPATOLOGY 1998; 27: 1517-1523.
14. Weissenborn K, Heidenreich S, Ennen J, Ruckert N. Attention deficit in minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 13-19.
15. Weissenborn K, Giewekemeyer K, Heidenreich S, Bokemeyer M, Berding G, Ahl B. Attention, memory, and cognitive function in hepatic encephalopathy. Metab Brain Dis 2005; 20: 259-367.
16. Amodio P, Schiff S, Del Piccolo F, Mapelli D, Gatta A, Umiltà C. Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting, and focusing. Metab Brain Dis 2005; 20: 115-127.
17. Sabri M, Liebenthal E, Waldron EJ, Medler DA, Binder JR. Attentional modulation in the detection of irrelevant deviance: a simultaneous ERP/fMRI study. J Cogn Neurosci 2006; 18: 689-700.
18. Baldeweg T, Klugman A, Gruzelier J, Hirsch S. Missmatch negativity potentials and cognitive impairment in schizofrenia. Schizophr Res 2004; 69: 200-217.
19. Light GA, Braff DL. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry 2005; 62: 127-136.
20. Korostenskaja M, Nikulin VV, Kicić D, Nikulina AV, Kähkönen S. Effects of NMDA receptor antagonist memantine on mismatch negativity. Brain Res Bull 2007; 72: 275-283.
21. Javitt DC. Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia. Audiol Neurootol 2000; 5: 207-215.
22. Salazar J, Ordoño F, Soriano S, Rueda M, Ojeda E, Cozar R, et al. Switch to ziprazidone treatment is associated with changes in MMN amplitude: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 573-574.
23. Monfort P, Muñoz MD, ElAyadi A, Kosenko E, Felipo V. Effects of hyperammonemia and liver disease on glutamatergic neurotransmission. Metab Brain Dis 2002; 17: 237-250.
24. Rodrigo R, Erceg S, Rodriguez-Diaz J, Saez-Valero J, Piedrafita B, Suarez I, et al. Glutamate-induced activation of nitric oxide synthase is impaired in cerebral cortex in vivo in rats with chronic liver failure. J Neurochem 2007; 102: 51-64.
25. Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with porto-caval shunts. HEPATOLOGY 2007; 46: 514-519.
26. Monfort P, Cauli O, Montoliu C, Rodrigo R, Llansola M, Piedrafita B, et al. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy. Therapeutical implications. Neurochem Int 2009; 55: 106-112.
27. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-583.
28. Williams and Wilkins (Baltimore, MD). World Medical Organization. Declaration of Helsinki. BMJ 1996; 313: 1448-1449.
29. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-773.
30. Schomerus H, Weissenborn K, Hamster W, Rückert N, Hecker H. PSE Syndrome Test Manual. Frankfurt, Germany: Swets Test Services; 1999.
31. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. HEPATOLOGY 2002; 35: 357-366.
32. Romero-Gomez M, Córdoba J, Jover R, Del Olmo JA, Ramírez M, Rey R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. HEPATOLOGY 2007; 45: 879-885.
33. Glaser MO, Glaser WR. Time course analysis of the Stroop phenomenon. J Exp Psychol Hum Percept Perform 1982; 8: 875-894.
34. Golden CJ. Stroop. In: Color and Word Test. Manual. (3rd ed.). Applied Psychology Publications. [In Spanish] Barcelona: TEA Editions; 2001.
35. rd ed.). Applied Psychology Publications. [ In Spanish] Barcelona: TEA Editions; 2001.
36. Yela M, López Ladrón L. A visuomotor coordination test. [In Spanish] Rev Psic Gral Apl 1956; 34: 409-421.
37. Yela M. A test of motor speed. [In Spanish] Rev Psic Gral Apl 1955; 33: 137-148.
38. Butz M, Timmermann L, Braun M, Groiss SJ, Wojtecki L, Ostrowski S, et al. Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy. Acta Neurol Scand 2010; 122: 27-35.
39. Montagnese S, Biancardi A, Schiff S, Carraro P, Carlà V, Mannaioni G, et al. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. HEPATOLOGY 2011; 53: 558-566.
40. Cauli O, Llansola M, Erceg S, Felipo V. Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra. J Hepatol 2006; 45: 654-661.
41. Erceg S, Monfort, P, Hernández-Viadel M, Rodrigo R, Montoliu C, Felipo V. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunt. HEPATOLOGY 2005; 45: 2-10.